Verve Therapeutics, Inc. (NASDAQ:VERV) is one of the Stocks With Huge Catalysts on the Horizon. On April 14, Verve ...

Detailed price information for Verve Therapeutics Inc (VERV-Q) from The Globe and Mail including charting and trades.

Verve Therapeutics (NASDAQ:VERV – Get Free Report) was upgraded by analysts at Wall Street Zen to a “hold” rating in a report issued on Saturday. A number of other brokerages also recently ...

Eli Lilly and Company (NYSE: LLY) and Verve Therapeutics, Inc. (NASDAQ: VERV) today announced that the tender offer to purchase all of the issued and outstanding shares ("Shares") of Verve's common ...

Eli Lilly and Company (NYSE:LLY) is one of the 13 Best Low Risk High Growth Stocks to Buy. Amid carrying on new studies, the company has agreed to acquire Verve Therapeutics. Eli Lilly and Company ...

Eli Lilly and Company has acquired Verve Therapeutics Inc., a Boston-based clinical-stage company developing genetic medicines for cardiovascular disease.

Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of Verve Therapeutics, Inc. (Nasdaq: VERV). Verve is a Boston-based clinical-stage company developing ...

Verve Therapeutics ( (VERV)) has shared an announcement. Verve Therapeutics announced the establishment of a retention bonus program for its employees, granting significant retention awards to key ...

Eli Lilly's acquisition of Vere Therapeutics promises to revolutionize cardiovascular care with innovative one-time gene ...

INDIANAPOLIS, July 24, 2025 /PRNewswire/ -- Eli Lilly and Company (LLY) and Verve Therapeutics, Inc. (VERV) today announced that the tender offer to purchase all of the issued and outstanding ...

Cautionary Statement Regarding Forward-Looking StatementsThis press release contains forward-looking statements regarding Lilly's acquisition of Verve, regarding prospective benefits of the ...